While the frequency of reported statin-associated myalgias is no different than placebo [11,12], severe muscle toxicity has been associated with allelic variation in the SLCO1B1 (OATP1B1) gene [10] which facilitates hepatic uptake of the drug. Here, SLCO1B1 is linked to Myalgia.